---
title: "NUVB.US (NUVB.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NUVB.US/news.md"
symbol: "NUVB.US"
name: "NUVB.US"
parent: "https://longbridge.com/en/quote/NUVB.US.md"
datetime: "2026-05-20T19:39:45.321Z"
locales:
  - [en](https://longbridge.com/en/quote/NUVB.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NUVB.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NUVB.US/news.md)
---

# NUVB.US (NUVB.US) — Related News

### [How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?](https://longbridge.com/en/news/287097726.md)
*2026-05-20T16:42:45.000Z*
> Nuvation Bio's recent FDA acceptance of a supplemental New Drug Application for IBTROZI enhances its long-term investmen

### [Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer | NUVB Stock News](https://longbridge.com/en/news/286309195.md)
*2026-05-13T12:05:28.000Z*
> Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non

### [Nuvation Bio to Participate in Upcoming Investor Conferences](https://longbridge.com/en/news/285261213.md)
*2026-05-05T20:08:06.000Z*
> Nuvation Bio Inc., a leading oncology company, has recently disclosed that David Hung, M.D., the Founder, President, and

### [](https://longbridge.com/en/news/285248639.md)
*2026-05-05T18:14:24.000Z*
> Nuvation Bio shares are trading higher after the company reported in-line Q1 EPS results and better-than-expected sales 

### [Wedbush Keeps Their Buy Rating on Nuvation Bio (NUVB)](https://longbridge.com/en/news/285220001.md)
*2026-05-05T13:47:25.000Z*
> Wedbush analyst David Nierengarten has reaffirmed a Buy rating on Nuvation Bio (NUVB) with a price target of $11.00. Nie